Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies (opens in new window) for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Manage cookies
Accept & continue
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • EU and BioNTech/Pfizer clash over reduced vaccine deliveries
    • China imposes sanctions on Trump officials including Mike Pompeo
    • Joe Biden sworn in as 46th US president
    • England’s lockdown fails to suppress rise in Covid transmissions
    • Biden signals return to normality on first day as president
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • QAnon in crisis as day of reckoning fails to materialise
    • China imposes sanctions on Trump officials including Mike Pompeo
    • Biden inauguration live: President signs order bringing US back to Paris climate accord – as it happened
    • Joe Biden sworn in as 46th US president
    • Baupost’s Seth Klarman compares investors to ‘frogs in boiling water’
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • BioNTech/Pfizer vaccine found effective against Covid-19 variant
    • Cheap antiparasitic could cut chance of Covid-19 deaths by up to 75%
    • Crackdown on Jack Ma’s empire gathers pace despite reappearance
    • Beckhams pay themselves healthy dividend even as losses deepen
    • QuantumScape: can battery pioneer live up to the hype?
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Baupost’s Seth Klarman compares investors to ‘frogs in boiling water’
    • Crises facing Biden threaten to create vicious cycles
    • Higher inflation is coming and it will hit bondholders
    • Time to look again at the financial system’s dangerous faultlines
    • Singapore steps up bid to become Asia Spacs hub
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Democratic Unionists are now Irish reunification’s secret weapon
    • Vaccines won’t get us back in the office any time soon
    • Joe Biden embraces his inner radical to confront winter of peril
    • Crises facing Biden threaten to create vicious cycles
    • The right answer to Xi Jinping is a one-China policy
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Vaccines won’t get us back in the office any time soon
    • Disabled workers find an upside in new working practices
    • When combining a senior job with study — when should I apply for my next role?
    • The pandemic tests a new generation of graduate trainees
    • How acts of leadership kindness make everyone better
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Six films to watch this week
    • Why does Davos Man get it so wrong?
    • Millions of people face tax return fines due to Covid, body warns
    • The new codes of White House dressing
    • The fight for the future of America’s local newspapers
  • How to Spend It
  • Sign In
  • Subscribe
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

$50 for your first 3 months Get the print edition and steer from crisis to recovery

Subscribe now

Cannabis industry

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Monday, 11 January, 2021
    Cannabis groups race to become first to win London listing

    Groups eye IPOs after financial regulator sets out rules for sector

  • Sunday, 10 January, 2021
    UK grants second only licence to grow medical marijuana

    Start-up secures first permit in more than 20 years for commercial cannabis cultivation

  • Wednesday, 30 December, 2020
    ETF HubThe latest news on ETFs
    Cannabis ETF inflows jump but potential problems persist

    Lack of investment-grade companies and questions over legality run counter to optimism

  • Wednesday, 16 December, 2020
    Lex
    Tilray/Aphria: greener grass Premium

    The happy, hazy days of 2018 look a long way away

  • Wednesday, 25 November, 2020
    Jay-Z
    It’s a hard SPAC life, for us

    How to deal with social injustice via the magic of the capital markets, and Jay-Z.

  • Wednesday, 4 November, 2020
    Recreational drugs
    Voters in Washington DC and Oregon endorse psychedelic drugs

    Biotech bosses hail breakthrough as magic mushroom ingredient decriminalised in parts of US

  • Friday, 30 October, 2020
    New Zealand
    New Zealand turns down cannabis but says yes to euthanasia

    Prime minister and a former leader backed the campaign to legalise pot

  • Wednesday, 21 October, 2020
    Lex
    Medical cannabis: duds and buds Premium

    Further liberalisation would lift many constraints, including the ability of institutions to invest

  • Tuesday, 22 September, 2020
    London-based manager aims to raise Europe’s biggest cannabis fund

    Chrystal Capital hopes to profit from legalisation moves even though shares in sector have struggled

  • Promoted Content
  • Friday, 18 September, 2020
    Financial watchdog sets out rules for UK cannabis listings

    FCA guidance clears way for companies providing products for medical use to float on stock exchange

  • Monday, 14 September, 2020
    Special Report
    Exchange Traded Funds

    Gold stands out in a dazzling year for the industry. Plus: finance experts look at how best to invest for Brexit; actively managed ETFs tested as investors switch focus; what is driving rapid growth in Asia and will it last?

  • Monday, 24 August, 2020
    UK cannabis groups push government to ease trade restrictions

    Companies warn current regulations will encourage investment to shift elsewhere in Europe

  • Saturday, 6 June, 2020
    News in-depth
    Uruguay cannabis producer sets sights on global dominance

    Silverpeak subsidiary aims to become world’s largest producer of medicinal marijuana by 2025

  • Tuesday, 28 April, 2020
    Cannabis sales surge during pandemic spurs Hightimes deal

    Magazine group buys outlets from one of America’s largest retail and wholesale marijuana distributors

  • Friday, 20 March, 2020
    Coronavirus pandemic
    US companies vie to be declared ‘essential’ in crisis

    Everyone from pet stores to cannabis growers are trying to avoid being closed during the coronavirus outbreak

  • Wednesday, 26 February, 2020
    FT MagazineGillian Tett
    An all-American approach to legalising marijuana

    US drug laws are complex, contradictory and affect black communities disproportionately

  • Friday, 14 February, 2020
    Pot of gold: could you be a cannabis farmer?

    UK smallholders hope to cash in on the CBD oil craze, as regulations relax worldwide

  • Monday, 20 January, 2020
    Patti Waldmeir
    Financial atonement for racism in the US ‘blue bubble’

    A $10m fund for reparations to black residents of Evanston faces a struggle to be more than symbolic

  • Monday, 6 January, 2020
    LexExchange traded funds
    Medical cannabis: dope hope Premium

    Investors in a pioneering fund should brace themselves for a rollercoaster ride

  • Sunday, 5 January, 2020
    High demand prompts launch of Europe’s first cannabis ETF

    Similar products in North America have proved popular despite a poor year for the sector

  • Thursday, 5 December, 2019
    News in-depth
    US cannabis companies struggle to secure insurance

    Insurers remain cautious in taking on risk, resulting in higher premiums

  • Wednesday, 4 December, 2019
    News in-depth
    How pot stocks lost their highs

    Momentum has stalled in key markets such as New York, New Jersey and Connecticut

  • Friday, 22 November, 2019
    Canada’s cannabis mountain swells to 400 tonnes

    Pot price falls and inventories grow as legal and illicit markets compete for customers

  • Wednesday, 30 October, 2019
    Adventurous InvestorDavid Stevenson
    Cannabis remains an investment market worth watching

    Promises of huge growth are yet to materialise — but there’s huge potential

  • Wednesday, 16 October, 2019
    Canopy wins UK’s medical cannabis bulk import licence

    Secret Buckinghamshire warehouse can store enough cannabis to supply 5,000 patients a month

Previous You are on page 1 Next

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2021. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Graphics
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In